Summary
This prediction ended on 03.11.22 with a price of €46.20. The price of Roku decreased from the start of the prediction. Compared to the start price this resulted in a performance of -17.36%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Roku | 2.598% | 2.598% | 21.785% | 50.507% |
| iShares Core DAX® | -3.520% | -4.987% | 1.926% | 50.820% |
| iShares Nasdaq 100 | 0.261% | 1.102% | 15.434% | 90.843% |
| iShares Nikkei 225® | -4.953% | -3.352% | 29.010% | 51.211% |
| iShares S&P 500 | -0.823% | -0.042% | 10.814% | 62.945% |
According to BiotechBee what are the pros and cons of Roku for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Roku diskutieren
Sell mit Kursziel 43,0